PRPO
Precipio·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Signals Analysis
Bullish signal 1
Bearish signal 0
EPS Beats Expectation
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About PRPO
Precipio, Inc.
A healthcare company focused on cancer diagnostics
Life Science Tools and Services
03/06/1997
06/30/2017
NASDAQ Stock Exchange
54
12-31
Common stock
4 Science Park, New Haven, CT 06511
--
Precipio, Inc., was incorporated in Delaware on March 6, 1997. GMO, the company is a global advance in personalized medicine in the detection of cancer and the treatment of hereditary diseases through its proprietary molecular technology and world-class clinical and scientific research services. The organization and review of GMO's business is presented by two complementary business units managed along its product line and below; genetic analysis platform and laboratory services.
Earnings Call
Q1/2025
Estimate EPS--
Actual EPS-0.59
Estimate Revenue--
Actual Revenue4.93M
Precipio's Q1 2025: Unpacking Contradictions on FDA Impact, Revenue Growth, and Margin Improvements
May 20,2025 11:50
Earnings Decrypt
Earnings Decrypt
Q2/2025
Estimate EPS--
Actual EPS0.05
Estimate Revenue--
Actual Revenue5.65M
Precipio's Q2 2025 Earnings Call: Navigating Contradictions in Revenue Growth, Breakeven, and Pathology Services Performance
Aug 14,2025 09:16
Earnings Decrypt
Earnings Decrypt
Company Financials
EPS
PRPO has released its 2025 Q2 earnings. EPS was reported at 0.05, versus the expected 0, beating expectations. The chart below visualizes how PRPO has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
PRPO has released its 2025 Q3 earnings report, with revenue of 6.77M, reflecting a YoY change of 29.91%, and net profit of -79.00K, showing a YoY change of 87.38%. The Sankey diagram below clearly presents PRPO's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
